Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ABBVIE-INC-12136589/news/AbbVie-Presents-New-Positive-Late-Breaking-Data-from-Two-Phase-3-Psoriasis-Trials-of-Risankizumab-26013239/?utm_source=whatsapp&utm_medium=social&utm_campaign=share